Citizens Business Bank Abb Vie Inc. Transaction History

Citizens Business Bank

  • $476 Million
  • Q3 2024

A detailed history of Citizens Business Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Citizens Business Bank holds 32,557 shares of ABBV stock, worth $5.86 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
32,557
Previous 32,544 0.04%
Holding current value
$5.86 Million
Previous $5.58 Million 15.19%
% of portfolio
1.35%
Previous 1.21%

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 19, 2024
SELL
$163.84 - $199.33 $127,467 - $155,078
-778 Reduced 2.39%
31,779 $6.28 Million
Q3 2024

Nov 07, 2024
BUY
$163.84 - $199.33 $2,129 - $2,591
13 Added 0.04%
32,557 $6.43 Million
Q2 2024

Aug 02, 2024
BUY
$154.79 - $180.76 $69,191 - $80,799
447 Added 1.39%
32,544 $5.58 Million
Q1 2024

Apr 17, 2024
SELL
$159.82 - $182.1 $78,151 - $89,046
-489 Reduced 1.5%
32,097 $5.84 Million
Q4 2023

Feb 05, 2024
SELL
$137.6 - $154.97 $377,024 - $424,617
-2,740 Reduced 7.76%
32,586 $5.05 Million
Q3 2023

Nov 02, 2023
SELL
$133.59 - $154.65 $187,827 - $217,437
-1,406 Reduced 3.83%
35,326 $5.27 Million
Q2 2023

Aug 07, 2023
BUY
$132.51 - $164.9 $154,374 - $192,108
1,165 Added 3.28%
36,732 $4.95 Million
Q1 2023

May 09, 2023
SELL
$144.61 - $166.54 $203,466 - $234,321
-1,407 Reduced 3.81%
35,567 $5.67 Million
Q4 2022

Feb 07, 2023
SELL
$138.31 - $165.87 $12,447 - $14,928
-90 Reduced 0.24%
36,974 $5.98 Million
Q3 2022

Nov 03, 2022
BUY
$134.21 - $153.93 $4.97 Million - $5.71 Million
37,064 New
37,064 $4.97 Million
Q2 2022

Nov 18, 2022
BUY
$137.62 - $174.96 $22,294 - $28,343
162 Added 0.25%
65,800 $10.1 Million
Q1 2022

Nov 18, 2022
SELL
$131.98 - $163.75 $776,834 - $963,832
-5,886 Reduced 8.23%
65,638 $10.6 Million
Q4 2021

Nov 18, 2022
SELL
$107.43 - $135.93 $46,624 - $58,993
-434 Reduced 0.6%
71,524 $9.69 Million
Q3 2021

Nov 18, 2022
SELL
$106.4 - $120.78 $8,724 - $9,903
-82 Reduced 0.11%
71,958 $7.76 Million
Q2 2021

Nov 18, 2022
BUY
$105.21 - $117.21 $23,777 - $26,489
226 Added 0.31%
72,040 $8.12 Million
Q1 2021

Nov 18, 2022
BUY
$102.3 - $112.62 $1.11 Million - $1.22 Million
10,848 Added 17.79%
71,814 $7.77 Million
Q4 2020

Nov 18, 2022
SELL
$80.49 - $108.67 $72,682 - $98,129
-903 Reduced 1.46%
60,966 $6.53 Million
Q3 2020

Nov 18, 2022
BUY
$85.91 - $100.83 $637,538 - $748,259
7,421 Added 13.63%
61,869 $5.42 Million
Q2 2020

Nov 18, 2022
BUY
$73.37 - $98.18 $683,588 - $914,743
9,317 Added 20.64%
54,448 $5.35 Million
Q1 2020

Nov 18, 2022
BUY
$64.5 - $97.79 $48,697 - $73,831
755 Added 1.7%
45,131 $3.44 Million
Q4 2019

Nov 18, 2022
SELL
$72.13 - $90.25 $81,579 - $102,072
-1,131 Reduced 2.49%
44,376 $3.93 Million
Q3 2019

Nov 18, 2022
SELL
$62.98 - $75.72 $40,055 - $48,157
-636 Reduced 1.38%
45,507 $3.45 Million
Q2 2019

Nov 18, 2022
SELL
$65.7 - $83.98 $54,333 - $69,451
-827 Reduced 1.76%
46,143 $3.36 Million
Q1 2019

Nov 18, 2022
SELL
$77.14 - $90.79 $1.07 Million - $1.26 Million
-13,883 Reduced 22.81%
46,970 $3.79 Million
Q4 2018

Nov 18, 2022
SELL
$77.85 - $96.01 $67,340 - $83,048
-865 Reduced 1.4%
60,853 $5.61 Million
Q3 2018

Nov 18, 2022
SELL
$88.91 - $98.84 $85,353 - $94,886
-960 Reduced 1.53%
61,718 $5.84 Million
Q2 2018

Nov 18, 2022
SELL
$89.78 - $106.23 $90,498 - $107,079
-1,008 Reduced 1.58%
62,678 $5.81 Million
Q1 2018

Nov 18, 2022
BUY
$92.01 - $123.21 $3,772 - $5,051
41 Added 0.06%
63,686 $6.03 Million
Q4 2017

Nov 18, 2022
SELL
$89.56 - $98.21 $35,017 - $38,400
-391 Reduced 0.61%
63,645 $6.16 Million
Q3 2017

Nov 18, 2022
SELL
$69.85 - $89.22 $221,913 - $283,451
-3,177 Reduced 4.73%
64,036 $5.69 Million
Q2 2017

Nov 18, 2022
BUY
N/A
30,149 Added 81.34%
67,213 $4.87 Million
Q1 2017

Nov 18, 2022
SELL
N/A
-3,700 Reduced 9.2%
36,532 $2.38 Million
Q4 2016

Nov 18, 2022
SELL
N/A
-9,496 Reduced 19.1%
40,232 $2.52 Million
Q3 2016

Nov 18, 2022
SELL
N/A
-1,751 Reduced 3.4%
49,728 $3.14 Million
Q2 2016

Nov 18, 2022
SELL
N/A
-1,900 Reduced 3.56%
51,479 $3.19 Million
Q1 2016

Nov 18, 2022
BUY
N/A
400 Added 0.76%
53,379 $3.05 Million
Q4 2015

Nov 18, 2022
SELL
N/A
-5,150 Reduced 8.86%
52,979 $3.14 Million
Q3 2015

Nov 18, 2022
SELL
N/A
-224 Reduced 0.38%
58,129 $3.16 Million
Q2 2015

Nov 18, 2022
SELL
N/A
-566 Reduced 0.96%
58,353 $3.92 Million
Q1 2015

Nov 18, 2022
BUY
N/A
4,597 Added 8.46%
58,919 $3.45 Million
Q4 2014

Nov 18, 2022
SELL
N/A
-5,070 Reduced 8.54%
54,322 $3.55 Million
Q3 2014

Nov 18, 2022
SELL
N/A
-709 Reduced 1.18%
59,392 $3.43 Million
Q2 2014

Nov 18, 2022
BUY
N/A
5,550 Added 10.17%
60,101 $3.39 Million
Q1 2014

Nov 18, 2022
BUY
N/A
22,349 Added 69.4%
54,551 $2.8 Million
Q3 2013

Nov 18, 2022
SELL
N/A
-920 Reduced 2.78%
32,202 $1.44 Million
Q2 2013

Nov 18, 2022
BUY
N/A
1,000 Added 3.11%
33,122 $1.37 Million
Q1 2013

Nov 18, 2022
SELL
N/A
-4,942
32,122 $1.31 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Citizens Business Bank Portfolio

Follow Citizens Business Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email